Health X Platform Limited has received its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The certificate demonstrates the company's adherence to regulatory requirements for dematerialisation processes during Q4 FY26.

Regulatory Compliance Certificate

The certificate was issued by MUFG Intime India Private Limited (formerly Link Intime India Private Limited), which serves as the registrar and share transfer agent for Health X Platform Limited. The compliance document was dated April 2, 2026, and subsequently filed with stock exchanges on April 6, 2026.

Dematerialisation Process Confirmation

MUFG Intime India confirmed that all securities received from depository participants for dematerialisation during Q4 FY26 were properly processed within prescribed timelines. The registrar verified that security certificates received for dematerialisation were confirmed or rejected appropriately, with physical certificates being mutilated and cancelled after due verification.

The confirmation also states that depositories' names have been substituted in the register of members as registered owners within the mandated timeframes, ensuring compliance with SEBI regulations.

Company Information

Health X Platform Limited, formerly known as Sastasundar Ventures Limited, operates under CIN L65993WB1989PLC047002. The company is listed on both BSE (Scrip Code: 533259) and NSE (Symbol: SASTASUNDR) with ISIN INE019J01013.

The quarterly compliance certificate filing reflects the company's ongoing commitment to maintaining regulatory standards and transparency in its share transfer and dematerialisation processes. This routine regulatory filing ensures continued compliance with SEBI depositories regulations.

Sastasundar ventures has announced that its promoter Mr. Banwari Lal Mittal has acquired additional equity shares in the company through market purchase. The transaction was disclosed under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, with the company informing both BSE and NSE on April 1, 2026.

Share Acquisition Details

The promoter acquired 5,000 equity shares on March 30, 2026, through market purchase. The transaction details are presented below:

Shareholding Pattern Changes

Following this acquisition, Mr. Banwari Lal Mittal's shareholding in Health X Platform Limited has increased marginally:

Promoter Information

Mr. Banwari Lal Mittal, identified as a promoter of the company, holds PAN ADMPM0065G and DIN 00365809. His registered address is 1 Ashoka Road, 7th Floor, Flat No. 7A, Kolkata - 700027. The disclosure confirms no trading in derivatives during this period.

Regulatory Compliance

The company has fulfilled its disclosure obligations under SEBI regulations by filing Form C with the designated stock exchanges. Health X Platform Limited trades on BSE with stock code 533259 and on NSE with symbol SASTASUNDR. The disclosure was signed by Company Secretary & Compliance Officer Pratap Singh and communicated to both exchanges as required under insider trading regulations.